SHARE

Bedford Man Sentenced To Federal Prison For Selling Prescription Drugs

BEDFORD, N.Y. -- A Bedford Hills man was sentenced to 54 months in jail, followed by five years of supervised release for illegally obtaining and distributing prescription drugs, according to Deirdre M, Daly, United States attorney for the District of Connecticut.

U.S. Attorney for Connecticut Deirde Daly

U.S. Attorney for Connecticut Deirde Daly

Photo Credit: File

Donald McCann, 32, was sentenced by Chief U.S. District Judge Janet C. Hall in New Haven. According to court documents and statements made in court, in May 2012, the Drug Enforcement Administration began an investigation into the filling of fraudulent prescriptions for oxycodone at pharmacies in Connecticut and New York through the use of fraudulent identifications. 

The investigation revealed that McCann purchased prescription paper and obtained identifying information to forge prescriptions from at least five doctors. McCann and another man, Jesse Kaplan then traveled to pharmacies together and used multiple aliases and fraudulent prescriptions to obtain oxycodone and hydromorphone. They then pooled, traded or shared their pills for further distribution, the DEA said.

Between December 2011 and October 2013, McCann fraudulently obtained more than 16,000 oxycodone pills.

McCann and Kaplan were arrested on Dec. 20, 2013. On March 13, McCann pleaded guilty to one count of conspiracy to distribute and to possess with intent to distribute oxycodone. On July 24, while he was released on bond, McCann was arrested in the Bronx for purchasing heroin. His bond was revoked on August 5.

McCann’s criminal history includes multiple arrests in Connecticut and New York for obtaining or attempting to obtain narcotics by using fraudulent prescriptions.

On November 18, 2014, Kaplan, who also pleaded guilty, was sentenced to 57 months of imprisonment.

The case was prosecuted by Assistant U.S. Attorney Vanessa Richards.

to follow Daily Voice Bedford and receive free news updates.

SCROLL TO NEXT ARTICLE